SEC Form 4 · accession 0001209191-18-051784
Alaunos Therapeutics, Inc. · TCRT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Braunstein
Director
Period of report
Sep 18, 2018
Accepted (ET)
Sep 20, 2018 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.00 | Sep 18, 2018 | A | 50,000 | A | — | Sep 18, 2028 | Common Stock | 50,000 | 50,000 | D |
Explanation of responses
- F125,000 shares shall vest on each of 9/18/2019 and 9/18/2020.